These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 21762754)

  • 1. Prime-boost immunisation against tropical theileriosis with two parasite surface antigens: evidence for protection and antigen synergy.
    Gharbi M; Darghouth MA; Weir W; Katzer F; Boulter N; Adamson R; Gilbert SC; Jongejan F; Westbroek I; Hall R; Tait A; Shiels B
    Vaccine; 2011 Sep; 29(38):6620-8. PubMed ID: 21762754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccination of calves with an attenuated cell line of Theileria annulata and the sporozoite antigen SPAG-1 produces a synergistic effect.
    Darghouth MA; Boulter NR; Gharbi M; Sassi L; Tait A; Hall R
    Vet Parasitol; 2006 Nov; 142(1-2):54-62. PubMed ID: 16870344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current status of vaccine development against Theileria parasites.
    Morrison WI; McKeever DJ
    Parasitology; 2006; 133 Suppl():S169-87. PubMed ID: 17274845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune responses against a liver-stage malaria antigen induced by simian adenoviral vector AdCh63 and MVA prime-boost immunisation in non-human primates.
    Capone S; Reyes-Sandoval A; Naddeo M; Siani L; Ammendola V; Rollier CS; Nicosia A; Colloca S; Cortese R; Folgori A; Hill AV
    Vaccine; 2010 Dec; 29(2):256-65. PubMed ID: 21029806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunity and vaccine development in the bovine theilerioses.
    Boulter N; Hall R
    Adv Parasitol; 1999; 44():41-97. PubMed ID: 10563395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of three recombinant multi-antigenic vaccines composed of surface and secretory antigens of Toxoplasma gondii in murine models of experimental toxoplasmosis.
    Dziadek B; Gatkowska J; Brzostek A; Dziadek J; Dzitko K; Grzybowski M; Dlugonska H
    Vaccine; 2011 Jan; 29(4):821-30. PubMed ID: 21087690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of protective immunity to Theileria annulata using two major merozoite surface antigens presented by different delivery systems.
    d'Oliveira C; Feenstra A; Vos H; Osterhaus AD; Shiels BR; Cornelissen AW; Jongejan F
    Vaccine; 1997 Nov; 15(16):1796-804. PubMed ID: 9364686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterologous prime-boost vaccination with a non-replicative vaccinia recombinant vector expressing LACK confers protection against canine visceral leishmaniasis with a predominant Th1-specific immune response.
    Ramos I; Alonso A; Marcen JM; Peris A; Castillo JA; Colmenares M; Larraga V
    Vaccine; 2008 Jan; 26(3):333-44. PubMed ID: 18093705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prime and boost immunization with influenza and adenovirus encoding the Toxoplasma gondii surface antigen 2 (SAG2) induces strong protective immunity.
    Machado AV; Caetano BC; Barbosa RP; Salgado AP; Rabelo RH; Garcia CC; Bruna-Romero O; Escriou N; Gazzinelli RT
    Vaccine; 2010 Apr; 28(18):3247-56. PubMed ID: 20189485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal antibody parameters of cattle and calves receiving EG95 vaccine to protect against Echinococcus granulosus.
    Heath DD; Robinson C; Lightowlers MW
    Vaccine; 2012 Nov; 30(50):7321-6. PubMed ID: 22981849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the recognition of Theileria parva vaccine candidate antigens by cytotoxic T lymphocytes from Zebu cattle.
    Akoolo L; Pellé R; Saya R; Awino E; Nyanjui J; Taracha EL; Kanyari P; Mwangi DM; Graham SP
    Vet Immunol Immunopathol; 2008 Feb; 121(3-4):216-21. PubMed ID: 17983665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of tropical theileriosis with attenuated schizont vaccine in China.
    Yin H; Luo J; Lu W
    Vaccine; 2008 Dec; 26 Suppl 6():G11-3. PubMed ID: 19178886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reciprocal cross-protection induced by sporozoite antigens SPAG-1 from Theileria annulata and p67 from Theileria parva.
    Hall R; Boulter NR; Brown CG; Wilkie G; Kirvar E; Nene V; Musoke AJ; Glass EJ; Morzaria SP
    Parasite Immunol; 2000 May; 22(5):223-30. PubMed ID: 10792761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective vaccination against experimental canine visceral leishmaniasis using a combination of DNA and protein immunization with cysteine proteinases type I and II of L. infantum.
    Rafati S; Nakhaee A; Taheri T; Taslimi Y; Darabi H; Eravani D; Sanos S; Kaye P; Taghikhani M; Jamshidi S; Rad MA
    Vaccine; 2005 May; 23(28):3716-25. PubMed ID: 15882533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of recombinant sporozoite antigen SPAG-1 as a vaccine candidate against Theileria annulata by the use of different delivery systems.
    Boulter N; Brown D; Wilkie G; Williamson S; Kirvar E; Knight P; Glass E; Campbell J; Morzaria S; Nene V; Musoke A; d'Oliveira C; Gubbels MJ; Jongejan F; Hall R
    Trop Med Int Health; 1999 Sep; 4(9):A71-7. PubMed ID: 10540314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The protection afforded to cattle immunized with Theileria annulata infected cell line is enhanced by subunit vaccine candidate TaSP.
    Saaid AA; Salih DA; Elhaj LM; Abdalla MA; Baumann M; Obara I; Ahmed JS; Clausen PH; El Hussein ARM
    Transbound Emerg Dis; 2020 Mar; 67 Suppl 1():26-34. PubMed ID: 32174037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A dual role for immunosuppressor mechanisms in infection with Theileria annulata: well-regulated suppressor macrophages help in recovery from infection; profound immunosuppression promotes non-healing disease.
    Preston PM; Darghouth M; Boulter NR; Hall FR; Tall R; Kirvar E; Brown CG
    Parasitol Res; 2002 Jun; 88(6):522-34. PubMed ID: 12107474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A heterologous prime/boost immunisation strategy protects against virulent E. ruminantium Welgevonden needle challenge but not against tick challenge.
    Pretorius A; van Kleef M; Collins NE; Tshikudo N; Louw E; Faber FE; van Strijp MF; Allsopp BA
    Vaccine; 2008 Aug; 26(34):4363-71. PubMed ID: 18602727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of recombinant antigen vaccines for the control of theileriosis.
    Musoke AJ; Nene V
    Parassitologia; 1990 Apr; 32(1):73-85. PubMed ID: 2149448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review on the experience with live attenuated vaccines against tropical theileriosis in Tunisia: considerations for the present and implications for the future.
    Darghouth MA
    Vaccine; 2008 Dec; 26 Suppl 6():G4-G10. PubMed ID: 19178892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.